Suicide gene therapy

Advances in Experimental Medicine and Biology

Volumn 465, Issue , 2000, Pages 411-422

  Freeman, S M ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; ALPHA INTERFERON; CYTOSINE DEAMINASE; DNA POLYMERASE; FLUCYTOSINE; FLUOROURACIL; GANCICLOVIR; PRODRUG; THYMIDINE KINASE; TUMOR MARKER; TUMOR NECROSIS FACTOR; TUMOR VACCINE; VIRUS VECTOR;

ADENOVIRUS; ADVANCED CANCER; BRAIN TUMOR; CANCER GENETICS; CANCER INHIBITION; CANCER MORTALITY; CANCER PATIENT; CANCER RECURRENCE; CANCER REGRESSION; CARCINOGENESIS; CHEMOSENSITIVITY; GENE EXPRESSION; GENE THERAPY; GENE TRANSFER; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOSTIMULATION; MARKER GENE; NEUTROPENIA; OVARY CANCER; PHENOTYPE; PRIORITY JOURNAL; REVIEW; SUICIDE GENE; TUMOR LOCALIZATION;

ANIMALS; BIOLOGICAL MARKERS; CLINICAL TRIALS; CYTOSINE DEAMINASE; GENE THERAPY; HUMANS; MICE; NEOPLASMS; NUCLEOSIDE DEAMINASES; SIMPLEXVIRUS; THYMIDINE KINASE;

ADENOVIRIDAE;

EID: 0034475061     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: None     Document Type: Review

References (54)

1. A first step in the development of gene therapy for colorectal carcinoma: Cloning and sequencing and expression of escherichia coli cytosine deaminase
2. Development of anti-tumor immunity following thymidine kinase-mediated killing of experimental brain tumors
3. In vitro evidence that metabolic cooperation is reponsible for the Bystander Effect observed with HSV tk retroviral gene therapy
4. An HSVtk-mediated local and distant antitumor bystander effect in tumors of head and neck origin in athymic mice
5. Cancer statistics 1992
6. Combination gene therapy for liver metastasis of colon carcioma in vivo
7. Combination suicide and cytokine gene therapy for hepatic metastases of colon carcinoma: Sustained antitumor immunity prolongs animal survival
8. The "bystander effect" association of U87 cell death with ganciclovir-mediated apoptosis of nearby cells and lack of effect in athymic mice
9. 5-Fluorocytosine-induced eradication of murine adenocarcinomas engineered to express the cytosine deaminase suicide gene requires host immune competence and leaves an efficient memory
10. Inhibition of herpes simplex virus transformed and nontransformed cells by acycloguanosine: Mechanisms of uptake and toxicity
11. Selectivity of action of an antiherpetic agent 9-(2-hydroxyethoxymethyl) guanine
12. The chemotherapeutic exploitation of virus-specified enzymes
13. The prevalence of cancer. Estimates based on the Connecticut Tumor Registry
14. 9-{[2-hydroxy-1-(hydroxy-methyl) ethoxy] methyl} guanine: A selective inhibitor of herpes group virus replication
15. Tumor regression when a fraction of the tumor mass contains the HSV-TV gene
16. Treatment of ovarian cancer using HSV-TK gene-modified vaccine-regulatory issues
17. The bystander effect: Tumor regression when a fraction of the tumor mass is genetically modified
18. In vivo studies on the mechanism of the "Bystander Effect"
19. The role of cytokines in mediating the bystander effect using HSV-TK xenogeneic cells
20. Treatment of ovarian cancer using a gene-modified vaccine
21. In situ use of suicide genes for cancer therapy
22. Immune system in suicidegene therapy
23. Tumor killing using the HSV-TK suicide gene
24. Multidrug resistance in human cancer
25. Expression of the MDRI gene in human cancers
26. Metabolism of 5-fluorocytosine to 5-fluorouracil in human colorectal tumor cells transduced with the cytosine deaminase gene: Significant antitumor effects when only a small percentage of tumor cells express cytosine deaminase
27. Cytotoxic T cells from ovarian malignant tumors can recognize polymorphic epithelia mucin core peptides
28. Implantable enzyme capsules for cancer chemotherapy from bakers yeast cytosine deaminase immobilized on epoxy-acrylic resin and urethane prepolymer
29. The bystander effect in gene therapy: Great but how does it work
30. Purified herpes simplex thymidine kinase Retrovector particles. I. In vitro characterization, in situ transduction efficiency and histopathological analyses of gene therapy-treated brain tumors
31. Ovarian tumour antigens as potential targets for immune gene therapy
32. Bystander effect caused by suicide gene expression indicates the feasibility of gene therapy for hepatocellular carcinoma
33. The TMC Worldwide Gene Therapy Enrollment Report (June 1996)
34. Drug sensitivity ("suicide") genes for selective cancer chemotherapy
35. Curability of tumors bearing herpes thymidine kinase genes transferred by retroviral vectors
36. Lymphoma regression induced by ganciclovir in mice bearing a herpesthymidine kinase transgene
37. Tumor chemosensitivity conferred by inserted herpes thymidine kinase genes: Paradigm for a prospective cancer control strategy
38. Anticellular effects of 9-(2-hydroxy-ethoxymethyl) guanine against herpes simplex virus-transformed cells
39. Antineoplastic effects in rats of 5-fluorocytosine in combination with cytosine deaminase capsules
40. Inhibition of HSV-transformed murine cells by nucleoside analogs, 2′-NDG and 2′-nor-cGMP: Mechanisms of inhibition and reversal by exogenous nucleosides
41. The effect of thymidine kinase transduction and ganciclovir therapy on tumor vasculature and growth of 9L gliomas in rats
42. In vivo analysis of the "bystander effect" a cytokine cascade
43. Expression of costimulatory molecules: B7 and ICAM up-regulation after treatment with a suicide gene
44. Gene therapy for cancer. What have we done and where are we going?
45. Implantable encapsulated cytosine deaminase havine 5-fluorocytosine deaminating activity
46. Cure of mice with established metastatic friend leukemia cell tumors by a combined therapy with tumor cells expressing both intereron-alpha I and herpes simplex thymidine kinase followed by ganciclovir
47. Successful gene therapy has researchers looking for the bystander effect
48. Activity of 9-[2-hydroxy-(hydroxymethyl) ethoxymethyl] guanine in the treatment of cytomegalovirus pneumonia
49. Shock and tissue injury induced by recombinant human cachectin
50. A more potent bystander cytocidal effect elicited by tumor cells expressing the herpes simples virus-thymidine kinase gene than by fibroblast virus-producer cells in vitro
51. Systemic gene therapy of murine melanoma using tissue specific expression of the HSVtk gene involves an immune component
52. Generation of an anti-tumour immune response in a non-immunogenic tumour. HSVtk killing in vivo stimulates a monocuclear cell infiltrate a th1-like profile of intratumoural cytokine expression
53. Targeted gene therapy for cancer: Herpes simplex virus thymidine kinase gene-mediated cell killing leads to anti-tumour immunity that can be augmented by coexpression of cytokines in the tumour cells
54. Bystander tumoricidal effect in the treatment of experimental brain tumors